Will Little-Known Company’s Inhaled Candidate Take Down InterMune-Roche’s Pirfenidone? - Avalyn Pharma Inc

Avalyn Pharma Inc

About
Therapeutic Focus
Pipeline
- Overview
- AP01
- AP02
- AP02-DP
- AP03
- AP04
- AP0X
Patients
- Overview
- Expanded Access
News & Events
- News
- Events
Careers
- Overview
- Open Positions
Contact

©2023 Avalyn Pharma Inc
All Rights Reserved.

Avalyn Pharma Headquarters

701 Pike Street
Suite 1500
Seattle, WA 98101

Privacy Policy

Terms of Use

MENU

About
Therapeutic Focus
Pipeline
- Overview
- AP01
- AP02
- AP02-DP
- AP03
- AP04
- AP0X
Patients
- Overview
- Expanded Access
News & Events
- News
- Events
Careers
- Overview
- Open Positions
Contact